Increase in direct costs for health systems due to lupus nephritis: the case of Colombia
ABSTRACT Objective Lupus nephritis is one of the most severe complications of systemic lupus erythematosus and it has been estimated that can occur in up to 60% of patients. Direct costs of lupus nephritis have not been studied in developing countries. This study aimed to describe lupus nephritis...
Main Authors: | Sergio I Prada, Ana M Pérez, Ivana Nieto-Aristizábal, Gabriel J Tobón |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2022-04-01
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100231&tlng=en |
Similar Items
-
Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01) -
Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01) -
Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01) -
Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01) -
Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis
by: Yi Tong V. Aw, et al.
Published: (2023-03-01)